agilon health, inc. (AGL) stock plummeted 15.98% in the after-hours trading session on Tuesday, following the company's disappointing fourth quarter 2024 earnings results and weak guidance for the upcoming fiscal year.
The healthcare services company specializing in senior care reported adjusted earnings per share of -$0.26 for Q4 2024, missing analyst estimates of -$0.23 per share. Revenue rose 44.2% year-over-year to $1.52 billion, in line with expectations. However, agilon health's adjusted EBITDA of -$83.97 million significantly lagged the consensus estimate of -$69.92 million.
More concerning was agilon health's outlook for fiscal 2025. The company guided for revenue growth of just -2.2% year-over-year at the midpoint of its range, a sharp deceleration from the 40.7% growth achieved in fiscal 2024. agilon health's projected 2025 EBITDA guidance of -$75 million also fell short of analyst expectations, highlighting continued profitability challenges amid a "challenging Medicare Advantage environment."
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.